EP
Epigenomics AG
EPGNF · OTC
$1.12 +0.00% (+$0.00)
Market Cap 860.4K €
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
66 /100
Fair P/S 2.54x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 26.14%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 83.22%
Net margin 1,315.79%
Op. margin 1,231.19%
Quality
0 /100
Poor ROIC 33.23%
ROA 34.75%
Asset turnover 0.03x
Debt
100 /100
Low Current ratio 9.03x
Net debt/EBITDA -2.71x
Debt/Equity N/A
Stability
26 /100
Unstable Beta 0.87x
Rev. volatility 404.08%
EPS volatility 184.11%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EPGNF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Jason Wouhra
Employees
3
Headquarters
Heidelberg